SCHEMBL7180283

SCHEMBL7180283

CC=CCc1cc(CC=CC)c(OC(=O)C(C)(C)C)c(C=CC(=O)c2ccc(OC(=O)C(C)(C)C)cc2)c1OC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 7/20 0.43
ABCG2 Q9UNQ0 1/20 0.42
KRAS P01116 1/20 0.41
MAPT P10636 4/20 0.41
LMNA P02545 2/20 0.41
MAPK1 P28482 1/20 0.41
ELANE P08246 2/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TNFRSF1A P19438 1/20 0.39
F3 P13726 2/20 0.39
P4HB P07237 1/20 0.39
CALM1 P0DP23 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.39
XDH P47989 1/20 0.39
KMT2A Q03164 1/20 0.39
MAOA P21397 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7180278 1.00 PTPN1 (0.43) PTPN1ABCG2KRASMAPTLMNA
SCHEMBL9206450 0.91 KDM4E (0.43) PTPN1ABCG2MAPTLMNAALDH1A1
SCHEMBL9206440 0.91 KDM4E (0.43) PTPN1ABCG2MAPTLMNAALDH1A1
SCHEMBL7178939 0.90 MAOB (0.42) PTPN1ABCG2MAPTLMNAELANE
SCHEMBL7178934 0.90 MAOB (0.42) PTPN1ABCG2MAPTLMNAELANE
SCHEMBL7184599 0.89 MAPT (0.46) PTPN1ABCG2KRASMAPTLMNA
SCHEMBL7184593 0.89 MAPT (0.46) PTPN1ABCG2KRASMAPTLMNA
SCHEMBL7806429 0.89 ELANE (0.39) PTPN1ABCG2ELANE
SCHEMBL7184443 0.89 ELANE (0.39) PTPN1ABCG2ELANE
SCHEMBL7177693 0.88 PTPN1 (0.52) PTPN1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed